STUDENT UPDATES BY THE NUMBERS
Meet the PharmD Class of 2019
189
MARKET COMPETITION The elective course “Pharmaceutical Development and Commercialization” mirrors the challenges of commerce by requiring student teams to compete in developing and presenting a comprehensive plan for a new pharmaceutical product. Ed Lieskovan, PharmD ’85, MBA, teaches and coordinates the course, which is offered each spring. The most recent class took on the task of late-stage development and commercialization of a new agent to treat nonsmall cell lung cancer. Each team’s members assumed the roles of chief financial officer, chief medical officer, chief science officer, senior vice president of clinical development, senior vice president of regulatory affairs, vice president of international relations, and vice president of marketing and sales. The teams then presented their completed plans to a panel of judges from industry and academia. The winning team was led by Karen Kowalski as the senior vice president of clinical development. Others on the team include Timothy Liu, Anet Melkomian, Christy Harutunian, Derrick Kwok, Dorothy Jin and Heidi Chung.
MEMBERS OF THE ENTERING CLASS
829 APPLICANTS
3.5
AVERAGE UNDERGRADUATE GPA
Winning team members Timothy Liu, Derrick Kwok, Anet Melkomian, Adjunct Professor Ed Lieskovan, Dorothy Jin, Karen Kowalski, Christy Harutunian and Heidi Chung
STUDENT UPDATES Eliza Asherian, PharmD candidate, received a Provost Fellowship, which provides her with a stipend while she is a research assistant in the lab of Professor Daryl Davies. Jordan Despanie, PhD candidate, was awarded a two-year training grant from the USC Clinical and Translational Science Institute for his project on enhancing drug synergy in breast cancer. Zhen Meng, PhD candidate, received a poster award and was a selected speaker at the Salivary Glands and Exocrine Biology Gordon Research Conference in Galveston, Texas.
36
esults
>> USC SCHOOL OF PHARMACY